Table 3.
OCP discontinuation risk for Prescription-Only versus OTC users: Discontinuation due to pregnancy, side effects, or other reasons
| Hazard Ratio (95% CI) | |
|---|---|
| Source/Number of pill packs | |
| Cross-Border Pharmacy | [lsqb]Reference[rsqb] |
| El Paso Clinic, 1-5 pill packs | 1.80 (1.22, 2.65) |
| El Paso Clinic, ≥ 6 pill packs | 1.11 (0.66, 1.87) |
| Planned OCP Use | |
| 3 months or less | 3.40 (1.71, 6.74) |
| 4-12 months | 2.04 (1.09, 3.80) |
| Between 1 and 2 years | 1.55 (0.99, 2.43) |
| Two years or more | [lsqb]Reference[rsqb] |
| Don’t know/Not sure | 1.25 (0.77, 2.03) |
| Side effects of OCP use | |
| Did not report side effects | [lsqb]Reference[rsqb] |
| Reported side effects | 1.37 (0.96, 1.96) |
Model also controls for duration of OCP use at baseline, parity/marital status, nativity/education, border crossing frequency, US government assistance, US health insurance, age groups.